Flow and tDCS Evidence Flow Overview Flow Webinars In-clinic Resources Marketing Materials

Flow and tDCS Evidence Flow Overview Flow Webinars In-clinic Resources Marketing Materials

Flow & tDCS Evidence

Woodham, R.D., Selvaraj, S., Lajmi, N. et al.

Oct, 2024

A ten-week double-blinded randomised control trial to evaluate the effectiveness and tolerability of the Flow tDCS device with an additional ten-week follow-up.

Griffiths, C., McIlhiney, W., Evans, A., O’Neill-Kerr, A., et al.

Nov, 2024

Impact of Flow tDCS for Depression Treatment in a Community Mental Health Team Service: Depression, Functioning, and Health-Related Quality of Life Outcomes

Griffiths, C., Abdalla, S., Mcconnochie, M., Jiang, H.

Nov, 2024

Impact of Self-Administered Flow tDCS Depression Treatment in a Crisis Resolution & Home Treatment Service: Functioning and Health-Related Quality of Life Outcomes

Griffiths, C., McIlhiney, W., O’Neill-Kerr, A., Walker, K., and Stringer

Aug, 2024

Feasibility and impact review of at-home Flow treatment for CMHT patients

Griffiths, C., Jiang, H., Smart, D., Zafar, A.

Jul, 2024

Flow tDCS can effectively and efficiently be delivered through a primary healthcare general practice service and patients will choose to use. The widespread availability of tDCS in primary care general practice should be considered.

Baukaite, E., Noel-Johnson, A., Walker, K., Griffiths, C.

Jun, 2024

Experiences and Value of Flow; Used at Home for Specialist Perinatal Mental Health Service and Maternal Loss Psychology Service Patients with Depression

Griffiths, C., Maravic da Silva, K., Jiang, H., Smart, D., and Zafar, A.

May, 2024

Flow for Depression Treatment in a Primary Healthcare General Practice—Depression, Functioning, and Health-Related Quality of Life Outcomes

Griffiths, C. , Walker, K. , Willis, A.

Feb, 2024

Qualitative Study Exploring the Experience and Value of Flow - Community Mental Health

Griffiths, C. , Walker, K. , Jiang, H. , Noel-Johnson, A. and Zafar, A.

Nov, 2023

Qualitative Study Exploring the Experience and Value of Flow - Primary Care

Additional studies showcasing Flow

Home-based tDCS is a potential first line treatment for MDD that is acceptable and safe

Using Flow home-based tDCS in clinical practice; case series

Is Flow a potential first line of treatment for depression?

Additional studies reviewing tDCS

tDCS antidepressant effects peak at around 6 weeks

tDCS for depression is definitely effective (level A evidence)

A meta-analysis: tDCS was an effective intervention in reducing depressive symptoms